Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase (TLT) grants 7,860,000 stock options at $ 0.25

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Nov 28, 2022 12:10am

315 Views

Post# 35132753

RE:RE:RE:RE:RE:RE:RE:Theralase (TLT) grants 7,860,000 stock options at $ 0.25

NMIBC may not be the only feather in their cap for long. Early 2023 may see a phase 1 trial for NSCLC and/or GBM. Also, if the animal trial for the covid vaccine has gone well (scheduled to be completed in 2022) there may be another 2023 phase 1 trial in partnership with the Canadian government..

Benedictus wrote:

enriquesuave wrote: If you were Roger, what would you prefer. An eventual buyout at say 10$ per share( a modest $3 Billion buyout), or 30 cents per share and a $2 million salary? So $2 Million per year or $210 million on a buyout. This is not a trick question. IMHO

while $3B sounds great it seems highly unlikely. NMIBC annual peak sales is estimated at $1.1 - 1.7B and since nothing else in their pipeline is advanced,, NMIBC success would be the only feather in the cap, so to speak. $1.3 - 1.5B ($4 - $5 per share) would be a huge win imo but let's not count our chickens just yet...